Hikma Pharmaceuticals PLC financial statements, including revenue, expenses, profit, and loss

The total revenue of H5P for the last semiannual is 1.46 B EUR, and it's 9.86% higher compared to the previous semiannual. The net income of H1 24 is 210.91 M EUR.